DE-105 Ophthalmic Solution

DE-105 · Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DE-105 Ophthalmic Solution, covering 2012-11-22 to 2012-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect [Phase 2]